Loading...
XNAS
DRIO
Market cap52mUSD
Jul 09, Last price  
7.00USD
1D
-3.05%
1Q
-3.45%
Jan 2017
-99.46%
IPO
-99.84%
Name

DarioHealth Corp

Chart & Performance

D1W1MN
XNAS:DRIO chart
P/E
P/S
2.29
EPS
Div Yield, %
Shrs. gr., 5y
52.78%
Rev. gr., 5y
24.17%
Revenues
22m
-17.31%
0051,000823,0002,803,0005,170,0007,394,0007,559,0007,576,00020,513,00027,656,00020,352,00027,040,00022,359,000
Net income
-42m
L-2.42%
-5,686,573-13,931,778-12,877,000-7,142,000-10,887,000-15,743,000-17,803,000-17,736,000-29,445,000-76,761,000-62,193,000-59,427,000-42,747,000-41,714,000
CFO
-26m
L-32.73%
-2,982,680-7,599,723-8,581,000-6,277,000-8,379,000-10,619,000-11,470,000-15,725,000-17,736,000-50,409,000-47,845,000-30,379,000-38,562,000-25,941,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
IPO date
Mar 08, 2013
Employees
241
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT